Incidence and clinical characteristic of ocular surface manifestation: an evaluation of conjunctival swab results in Corona Virus 2019 (COVID-19) patients in Jakarta, Indonesia

Made Susiyanti1, Hisar Daniel1, Diah Faridah2, Dinda Arken Devona2, Pradnya Pramitha2, Budiman Bela3, Budi Haryanto4, Julie Dewi Barliana1, Dian Estu1, Andi Arus Victor1, Nina Dwi Putri5, Julius Candra1, Nathania Sutandi1, Rita S. Sitorus1
1Department of Ophthalmology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia
2Department of Ophthalmology, Faculty of Medicine Universitas Indonesia, Persahabatan Hospital, Jakarta, Indonesia
3Department of Clinical Microbiology, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia
4Department of Clinical Microbiology, Faculty of Medicine Universitas Indonesia, Persahabatan Hospital, Jakarta, Indonesia
5Department of Child Health, Faculty of Medicine Universitas Indonesia, Cipto Mangunkusumo National Referral Hospital, Jakarta, Indonesia

Tóm tắt

This study aimed to investigate the spectrum of ocular characteristics and viral presence in the conjunctival swab of patients with COVID-19. In this cross-sectional study, fifty-three patients were recruited from two COVID-19 referral hospitals in Jakarta (Cipto Mangunkusumo Hospital and Persahabatan Hospital) from July 2020 to March 2021. The inclusion criteria were patients who were suspected of or confirmed cases of COVID-19 with or without ocular symptoms. Demographic data, history of COVID-19 exposure, underlying medical condition, systemic symptoms, ocular symptoms, supporting laboratory results, reverse-transcriptase polymerase chain reaction (RT-PCR) of naso-oropharyngeal (NOP) swab and conjunctival swab were collected. Fifty-three patients who were suspected, probable or confirmed cases of Covid-19 were included. Forty-six out of 53 patients (86.79%) tested positive for either Covid-19 antibody rapid test or naso-oropharyngeal (NOP) swab. Forty-two patients tested positive for NOP swab. Fourteen out of 42 patients (33.33%) experienced symptoms of ocular infection including red eye, epiphora, itchy eyes, and eye discharge. None of these patients were tested positive for conjunctival swab. Two out of 42 patients (4.76%), who were tested positive for conjunctival swab, did not experience any ocular symptoms. Establishing the relationship between Covid-19 infection, ocular symptoms, and presence of SARS-CoV-2 virus on the ocular surface proves to be challenging. In Covid-19 patients, ocular symptoms did not warrant a positive conjunctival swab result. On the contrary, a patient without ocular symptoms can also have detectable presence of SARS-CoV-2 virus on the ocular surface.

Tài liệu tham khảo

Güemes-Villahoz N, Burgos-Blasco B, Arribi-Vilela A, Arriola-Villalobos P, Rico-Luna CM, Cuiña-Sardiña R et al (2021) Detecting SARS-CoV-2 RNA in conjunctival secretions: Is it a valuable diagnostic method of COVID-19? J Med Virol 93(1):383–388 Kumar K, Prakash AA, Gangasagara SB, Rathod SBL, Ravi K, Rangaiah A et al (2020) Presence of viral RNA of SARS-CoV-2 in conjunctival swab specimens of COVID-19 patients. Indian J Ophthalmol 68(6):1015–1017 Valente P, Iarossi G, Federici M, Petroni S, Palma P, Cotugno N et al (2020) Ocular manifestations and viral shedding in tears of pediatric patients with coronavirus disease 2019: a preliminary report. J aapos 24(4):212–215 Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L et al (2020) Characteristics of ocular findings of patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province. China JAMA Ophthalmol 138(5):575–578 Ozturk M, Kumova D, Alacam S, Erdogan H, Onder F (2021) Detection of coronavirus in tear samples of hospitalized patients with COVID-19. Int Ophthalmol 40(3):348–350. https://doi.org/10.1097/ICO.0000000000002562 Zhong Y, Wang K, Zhu Y, Lyu D, Yu Y, Li S et al (2021) Ocular manifestations in COVID-19 patients: a systematic review and meta-analysis. Travel Med Infect Dis 44:102191 Thapa B (2021) Role of eyes and eyes protection amidst SARS-CoV-2 infection. JNMA J Nepal Med Assoc 59(233):108–110 Chawhan A, Athale A, Khan K, Agarwal S, Paul R, Iyer K et al (2021) Detection of SARS-CoV-2 RNA in a conjunctival swab sample in real-time-polymerase chain reaction positive COVID-19 patients and its association with comorbidity and severity at a designated COVID-19 hospital in Central India. Indian J Ophthalmol 69(12):3633 Gasparini MS, Dos Santos LM, Hamade AM, Gross LG, Favarato AP, de Vasconcellos JP et al (2021) Identification of SARS-CoV-2 on the ocular surface in a cohort of COVID-19 patients from Brazil. Exp Biol Med (Maywood) 246(23):2495–2501 Hadrawi M, Malak M, Almahmoudi F, Mogharbel A, Rozy O, Hanafi S et al (2021) Testing the sensitivity of conjunctival swabs from confirmed COVID-19 patients. Clin Ophthalmol 15:2489–2496 Li X, Chan JF, Li KK, Tso EY, Yip CC, Sridhar S et al (2021) Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms. Infection 49(2):257–265 Vallejo-Garcia JL, Balia L, Raimondi R, Rustioni G, Camesasca FI, Borgia A et al (2021) Conjunctivitis as a sign of persistent SARS-COV-2 infection? An observational study and report of late symptoms. Eur J Ophthalmol 32(2):11206721211056594. https://doi.org/10.1177/11206721211056594 Sonmez A, Aydin Kurna S, Aslan FG, Kaplan FB, Acikalin B, Eker P (2022) SARS-COV-2 viral load in tears of patients with COVID-19 in the early symptomatic stages: comparison of two different tear sampling methods. Int Ophthalmol 42(8):2425–2438 Cheema M, Aghazadeh H, Nazarali S, Ting A, Hodges J, McFarlane A et al (2020) Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol 55(4):e125–e129 Xia J, Tong J, Liu M, Shen Y, Guo D (2020) Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 92(6):589–594 Zhou Y, Zeng Y, Tong Y, Chen C (2020) Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva. medRxiv. https://doi.org/10.1101/2020.02.11.20021956. Indonesia KKR (2020) Pedoman dan Pencegahan Pengendalian COVID-19 Health NIo. Clinical Spectrum of SARS-CoV-2 Infection 2021 [updated 19 October 2021. Available from: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/. Barnett BP, Wahlin K, Krawczyk M, Spencer D, Welsbie D, Afshari N et al (2020) Potential of Ocular Transmission of SARS-CoV-2: A Review. Vision (Basel) 4(3):40. https://doi.org/10.3390/vision4030040 Sopp NM, Sharda V (2021) An eye on COVID-19: a meta-analysis of positive conjunctival reverse transcriptase-polymerase chain reaction and SARS-CoV-2 conjunctivitis prevalence. Optom Vis Sci 98(5):429–436 de Freitas SD, de Sousa LB, Câmara NOS, de Freitas D, de Oliveira LA (2021) SARS-COV-2 and ocular surface: from physiology to pathology, a route to understand transmission and disease. Front Physiol 12:612319 Planas D, Veyer D, Baidaliuk A, Staropoli I, Guivel-Benhassine F, Rajah MM et al (2021) Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature 596(7871):276–280. https://doi.org/10.1038/s41586-021-03777-9 Kharel Sitaula R, Khatri A, Janani MK, Mandage R, Sadhu S, Madhavan HN et al (2020) Unfolding COVID-19: lessons-in-learning in ophthalmology. Clin Ophthalmol 14:2807–2820 Deng W, Bao L, Gao H, Xiang Z, Qu Y, Song Z et al (2020) Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. Nat Commun 11(1):4400 Karabela Y, Karabela SN, Ozbas M, Kasikci H, Kart YK (2021) Investigation of SARS-CoV-2 in tear and conjunctival secretions of hospitalized patients with clinically-confirmed COVID-19 pneumonia. BMC Infect Dis 21(1):918 Shemer A, Einan-Lifshitz A, Itah A, Dubinsky-Pertzov B, Pras E, Hecht I (2021) Ocular involvement in coronavirus disease 2019 (COVID-19): a clinical and molecular analysis. Int Ophthalmol 41(2):433–440 Kaya H, Caliskan A, Okul M, Sari T, Akbudak IH (2020) Detection of SARS-CoV-2 in the tears and conjunctival secretions of Coronavirus disease 2019 patients. J Infect Dev Ctries 14(9):977–981 Cao K, Kline B, Han Y, Ying GS, Wang NL (2020) Current evidence of 2019 Novel Coronavirus Disease (COVID-19) ocular transmission: a systematic review and meta-analysis. Biomed Res Int 2020:7605453 Zhang X, Chen X, Chen L, Deng C, Zou X, Liu W et al (2020) The evidence of SARS-CoV-2 infection on ocular surface. Ocul Surf 18(3):360–362 Mahmoud H, Ammar H, El Rashidy A, Ali AH, Hefny HM, Mounir A (2020) Assessment of Coronavirus in the conjunctival tears and secretions in patients with SARS-CoV-2 infection in Sohag Province Egypt</p>. Clin Ophthalmol 14:2701–2708 Aggarwal K, Agarwal A, Jaiswal N, Dahiya N, Ahuja A, Mahajan S et al (2020) Ocular surface manifestations of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. PLoS One 15(11):e0241661 Ranzenigo M, Bruzzesi E, Galli L, Castagna A, Ferrari G (2021) Symptoms and signs of conjunctivitis as predictors of disease course in COVID-19 syndrome. J Ophthalmic Inflamm Infect 11(1):35 Szczęśniak M, Brydak-Godowska J (2021) SARS-CoV-2 and the eyes: a review of the literature on transmission, detection, and ocular manifestations. Med Sci Monit 27:e931863 Kaur P, Sehgal G, Shailpreet, Singh KD, Singh B (2021) Evaluation and comparison of conjunctival swab polymerase chain reaction results in SARS-CoV-2 patients with and without ocular manifestations. Indian J Ophthalmol 69(8):2211–2214. https://doi.org/10.4103/ijo.IJO_587_21 Ekici Gok Z, Gok A, Acun Delen L, Kasapoglu US, Gurbuz E, Mutlu K (2021) Evaluation of eye care and ocular findings in critically ill COVID-19 patients. Int J Clin Pract 75(12):e14909. https://doi.org/10.1111/ijcp.14909 Atum M, Boz AAE, Çakır B, Karabay O, Köroğlu M, Öğütlü A et al (2020) Evaluation of conjunctival Swab PCR results in patients with SARS-CoV-2 infection. Ocul Immunol Inflamm 28(5):745–748 Cheong KX (2020) Systematic review of ocular involvement of SARS-CoV-2 in Coronavirus Disease 2019. Curr Ophthalmol Rep 8(4):185–194